Uncoupling of XB/U-Cadherin-Catenin Complex Formation from Its Function in Cell-Cell Adhesion*

(Received for publication, November 7, 1996, and in revised form, February 20, 1997)

Silvia Finnemann Dagger , Ingrid Mitrik , Manuela Hess , Gabriele Otto and Doris Wedlich §

From the Department of Biochemistry, University of Ulm, D-89081 Ulm, Germany

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Xenopus XB/U-cadherin forms functional complexes with mouse alpha - and beta -catenins and p120cas when expressed in murine L-TK- fibroblasts. These cells were stably transfected with cDNAs encoding different cytoplasmic XB/U-cadherin mutants, each partially deleted in the different parts of the 38 most carboxyl-terminal amino acids. The binding of p120cas was not affected by carboxyl-terminal deletions, confirming its binding to a region more amino-terminal and distinct from the catenins. alpha - and beta -catenins associate with truncated XB/U-cadherins if either 19 amino acid half of the cadherin 38 amino acid tail is present, indicating that the site of catenin interaction is upstream of the deletions. However, for adhesive function of XB/U-cadherin constructs, the most carboxyl-terminal 19 amino acids are essential; if these amino acids are deleted, cadherin-catenin complexes unable to mediate cell-cell adhesion are formed. Nonadhesive complexes are solubilized by mild detergent, whereas functional complexes are stable. Provided that detergent stability of cadherin-catenin complexes is taken as a measure of their cytoskeletal association, our results give first evidence that cytoskeletal stabilization occurs independent of cadherin-catenin complex formation and requires the 19-amino acid cadherin carboxyl terminus.


INTRODUCTION

Xenopus XB/U-cadherin is a member of the classical cadherin family of calcium-dependent cell-cell adhesion molecules. As a maternal cadherin, XB/U-cadherin is inserted into all newly forming plasma membranes from maternal mRNA and protein stores (1). It contributes to interblastomere adhesion and, during gastrulation, promotes convergent-extension movements of mesodermal cells (2, 3). Dominant-negative expression of XB/U-cadherin deletion mutants in Xenopus embryos results in the malformation of neural tissues in the head region (3, 4). Sequence alignment and its tissue-specific expression pattern show that XB/U-cadherin is most closely related to mammalian P-cadherins (5).

To promote stable calcium-dependent cell adhesion, classical cadherins must be linked to cytoskeletal elements, putatively to actin microfilaments (6-8). Cytosolic catenins associate with the cadherin cytoplasmic domain, which shows the highest level of conservation on the amino acid level among classical cadherins of different types and species (9).

Previous studies showed that beta - and gamma -catenin, the latter of which is most likely identical to plakoglobin, bind to overlapping domains of the cadherin tail directly (10-12). alpha -Catenin interacts with sites shared by beta - and gamma -catenin linking the beta - or gamma -catenin-cadherin complex to the cytoskeleton (13, 14). Recently, other cytoplasmic proteins have been reported to interact with cadherin-catenin complexes; Knudsen et al. (15) have shown that alpha -catenin can bind directly to alpha -actinin, and p120cas has been found to associate with E-cadherin and the c-src kinase (16-18). The role of these proteins in the cadherin-catenin complex is still unknown.

Using E-cadherin as a model molecule, a number of studies set out to identify the cadherin-binding site for beta - or gamma -catenin. When E-cadherin mutants lacking more than 37 carboxyl-terminal amino acids were expressed in mouse fibroblasts, cadherin-catenin complex formation as well as E-cadherin-mediated adhesive function was completely abolished (19). However, although a larger portion of the E-cadherin cytoplasmic domain consisting of the carboxyl-terminal 72 amino acids was both essential and sufficient for its adhesive function and catenin binding, these terminal 37 amino acids were not (9, 20). More recently, the beta -catenin-binding domain of E-cadherin was assigned to a core region of 25 amino acids located 54 to 29 amino acids from the carboxyl terminus (21). At least partial phosphorylation of a cluster of eight serine residues within this binding site was found to be necessary for cadherin-catenin complex formation in transfected mouse fibroblasts (22).

In this study, we focus on the role of motifs within the 38 carboxyl-terminal amino acids in catenin complex formation of XB/U-cadherin and the induction of cell adhesion. Full-length XB/U-cadherin and four deletion mutants lacking different parts of the carboxyl-terminal 38 amino acids of XB/U-cadherin were stably expressed in murine L-TK- fibroblasts, as the most established expression system for the analysis of cadherin molecules. Catenins do not associate with mutant XB/U-cadherins lacking the carboxyl-terminal 32 amino acids but bearing sequences corresponding to the beta -catenin-binding sites reported for murine E-cadherin (21, 22). Complex formation and adhesive function are restored when the terminal 32 amino acids are replaced by the 19 carboxyl-terminal residues alone.

However, mutant XB/U-cadherin molecules truncated by these carboxyl-terminal 19 amino acids do not induce cell adhesion, although they associate with alpha - and beta -catenin at cell surfaces. Thus, cadherin-catenin complex formation itself is not sufficient to render transfectants of mutant cadherin adhesive. Nonadhesive complexes differ from functional ones in that they lack resistance to detergent. We conclude that the specific 19 amino acids of the XB/U-cadherin carboxyl terminus are required to link complexes to cytoskeletal elements. This stabilization is a prerequisite for cell-cell adhesion.

Here, we provide evidence that complex formation with catenins and cytoskeletal stabilization of complexes depend on different domains of the cadherin cytoplasmic tail. Our results complete earlier findings in that they reveal a novel aspect in the establishment of cadherin-mediated adhesion.


EXPERIMENTAL PROCEDURES

cDNA Constructs

Construction of the expression vectors for the full-length cDNA of XB/U-cadherin and the cDNA of XB/U-cadherin truncated by 38 carboxyl-terminal amino acids (XBDelta c38) have been described previously (23). Carboxyl-terminal deletion construct XBDelta c19 was generated by SpeI-DraII cleavage, truncated XBDelta c32 by EcoRI-TaqI cleavage of full-length XB/U-cadherin cDNA. In both cases, resulting fragments were religated in the presence of a NheI nonsense linker, causing frameshifts and producing stop codons downstream of the DraII and TaqI sites, respectively. The XBDelta c32 construct encodes for a random sequence of 12 amino acids following the cadherin sequence. The internal deletion mutant XBDelta i20 was generated by EspI-DraII restriction and religation of full-length XB/U-cadherin cDNA. Truncated forms of XB/U-cadherin were asymmetrically inserted into the polylinker of the mammalian expression vector pRc/CMV (Invitrogen). All constructs were controlled by DNA sequencing with a laser sequencer (Applied Biosystems, ABI 373 A).

Cells and Transfection

L-TK- cells (kindly provided by Dr. R. Kemler, Max Planck Institute, Freiburg, Germany) were grown, transfected, and selected as described previously (2, 23). Cadherin-positive cells were subcloned twice by limiting dilution. Several clonal cell lines expressing the full-length or the respective deleted forms, as well as pooled clones, were analyzed. Results of representative clonal cell lines are shown.

For metabolic radiolabeling of proteins, confluent monolayers of cells were preincubated with methionine-free Dulbecco's modified Eagle's medium (Life Technologies, Inc.) for 2 h. Fresh methionine-free medium supplemented with 50 µCi/ml [35S]L-methionine (1100 Ci/mmol, Amersham Corp.) was added for 16 h before the cells were harvested.

Antibodies

Previously characterized monoclonal antibody (mAb)1 6D5 raised against U-cadherin (24) was a gift from Dr. P. Hausen (Max Planck Institute, Tübingen, Germany). Peptide-specific polyclonal antibodies against alpha - and beta -catenin have been described elsewhere (25, 26) and were kindly provided by Dr. R. Kemler (Max Planck Institute, Freiburg, Germany). mAbs against gamma -catenin and p120cas were purchased from Transduction Laboratories.

Immunofluorescence Microscopy

Cells were grown to confluency on glass coverslips for at least 48 h before being fixed in 3% paraformaldehyde in PBS/Ca2+ (phosphate-buffered saline: 2.7 mM KCl, 137 mM NaCl, 0.15 mM KH2PO4, 0.7 mM NaH2PO4, and 0.75 mM CaCl2). For detergent extraction, cells were incubated for 5 min at 4 °C in PBS/Ca2+ containing 0.5% Nonidet P-40 prior to fixation. Indirect immunostaining was carried out as described previously (23), except that all antibodies were diluted in PBS/Ca2+. Cy3-conjugated goat anti-mouse IgG (Dianova) were used as secondary antibodies. Cells were viewed with a laser scanning confocal microscope (Leitz).

Western Blot, Immunoprecipitation, Surface Biotinylation, and Streptavidin-Agarose Precipitation

Confluent monolayers of cells were rinsed three times with PBS/Ca2+ and harvested. Cells were lysed in PBS/Ca2+ supplemented with 1% each of Triton X-100 and Nonidet P-40, 2 mM each of aprotinin, leupeptin, and pepstatin, 1 mM N-ethylmaleimide, and 2 mM each of iodoacetamide and phenylmethylsulfonyl fluoride (all from Sigma). Protein concentrations were determined by Bradford protein quantification. SDS-PAGE, immunoblotting, and immunoprecipitation, as well as biotinylation and streptavidin-agarose precipitation of cell surface proteins, were carried out as described previously (23). Immunoblot signals were scanned and quantified.

Cell Aggregation Assay

Cell monolayers that had just reached confluency were used for preparing single cells. The cell aggregation assay was performed according to the method described elsewhere (27). 3-4 × 105 cells were incubated at 37 °C with 1 mM CaCl2 or with 1 mM EGTA on a rotating platform at 80 rpm. Aggregation was stopped after 90 min. Cells were fixed by the addition of an equal volume of 5% paraformaldehyde in PBS/Ca2+. Aggregates were observed by phase contrast microscopy.


RESULTS

Construction and Expression of XB/U-Cadherin and Four Deletion Mutants

Four deletion mutants of the amphibian XB/U-cadherin sequence were constructed that lack 38 (XBDelta c38), 32 (XBDelta c32), or 19 (XBDelta c19) carboxyl-terminal amino acids or bear an internal deletion of 20 amino acids followed by 19 carboxyl-terminal amino acids of wild-type XB/U-cadherin (XBDelta i20). In the construct XBDelta c32, 12 random amino acids follow the truncated XB/U-cadherin-specific sequence. The carboxyl-terminal sequences of full-length XB/U-cadherin and the deletion mutants are shown in Fig. 1A.


Fig. 1. Comparison of carboxyl-terminal amino acids of XB/U-cadherin, its deletion constructs, and murine E-cadherin. A, schematic representation of XB/U-cadherin structure. Carboxyl-terminal amino acids of XB/U-cadherin and the four deletion constructs XBDelta c19, XBDelta c32, XBDelta i20, and XBDelta c38. B, alignment of carboxyl-terminal amino acids of XB/U-cadherin and murine E-cadherin. Conservative amino acid exchanges, which retain the chemical character of the residue, are indicated by asterisks. Exchanges altering the chemical identity of the site are indicated by circles. TM, transmembrane domain.
[View Larger Version of this Image (32K GIF file)]

To characterize the different mutants with respect to conserved sequence motifs, a sequence alignment of the last 52 carboxyl-terminal amino acids of XB/U-cadherin and murine E-cadherin was done in Fig. 1B. Although 11 exchanges were found in the region containing the beta -catenin-binding site, 5 of them were conservative. An accumulation of four exchanges follows directly downstream of the cluster of eight serine residues, which itself is conserved. Both proteins share a stretch of amino acids, "KLADMYGG," upstream of carboxyl-terminal glutamic or aspartic acid residues.

Cadherin protein levels did not differ by more than 18% among L-TK- cell lines expressing the different cadherin constructs under the control of the human cytomegalovirus promoter (Fig. 2A) analyzed by immunoblotting using mAb 6D5 against XB/U-cadherin. Mutant forms of XB/U-cadherin showed reduced molecular weights as expected from the respective cDNA truncations. Because cadherin expression has been reported to induce up-regulation of catenins in L-TK- fibroblasts (28), we assessed the steady-state levels of alpha - and beta -catenin proteins in the different mutant XB/U-cadherin-expressing cell lines. 20 µg of total protein per lane were analyzed by immunoblotting and quantified. Steady-state levels of the XB/U-cadherin constructs, alpha - and beta -catenin, were determined by analyzing 10 experiments. Fig. 2 shows one of these experiments as an example. Cadherin and catenin levels did not differ by more than 15% between experiments. Transfectants contained similar amounts of alpha -catenin (Fig. 2B), although in cells expressing full-length XB/U-cadherin or XBDelta i20, the amount of alpha -catenin was 135 and 130% compared with the other transfectants, respectively. The beta -catenin content varied extensively among transfected cell lines (Fig. 2C). beta -Catenin protein was at the detection limit in vector-transfected controls and cells expressing XBDelta c32 or XBDelta c38 and did in no experiment exceed 10% of the beta -catenin level reached in cells bearing intact XB/U-cadherin. In XBDelta i20 transfectants, we detected the largest amount of beta -catenin with an average of 133%, whereas cells expressing XBDelta c19 exhibited only 60% both compared with the amount of beta -catenin with the full-length XB/U-cadherin transfectants. Other proteins we studied while we characterized our cell lines, such as integrins, fibronectin, and laminin, did not detectably alter their expression level upon transfection of XB/U-cadherin constructs (data not shown).


Fig. 2. Protein expression of wild-type XB/U-cadherin, its deletion constructs, and catenins in cadherin-transfected L-TK- cells. 20 µg of total cellular proteins of untransfected L-TK- cells and of transfectants as given for each lane were separated on 7.5% SDS-polyacrylamide gels and transferred to nitrocellulose. Membranes were probed with mAb 6D5 against XB/U-cadherin (A), with peptide specific antibodies against alpha -catenin (B), or with peptide specific antibodies against beta -catenin (C). Positions of molecular weight standards are indicated on the left in thousands. Note that, here, we choose to show a short exposure of the Western blot detections, which allows us to see differences in expression levels most clearly.
[View Larger Version of this Image (34K GIF file)]

Complex Formation of XB/U-Cadherin and Its Mutants

Cadherin-catenin complex formation was studied by coprecipitation experiments. Cells were metabolically labeled with [35S]methionine for 16 h and lysed. Transfected cadherins were immunoprecipitated from cell lysates using mAb 6D5. Immunoisolated proteins were separated by SDS-PAGE. Fluorography of all samples showed signals corresponding to the respective forms of XB-cadherin (Fig. 3A, uppermost bands). Additionally, two bands migrating at 102 and 88 kDa coprecipitated with XB/U-cadherin-specific antibodies in cells expressing the full-length XB/U-cadherin as well as in cells bearing XBDelta c19 and XBDelta i20. Those mutants comigrated with the 102-kDa band in a way that the two bands could not be discriminated. With XBDelta c32 and XBDelta c38, no signals other than those corresponding to the respective mutant forms of XB/U-cadherin were detected. When mAb 6D5 immunoprecipitates from cell extracts were immunoblotted with alpha -catenin antibodies, the 102-kDa protein that coprecipitated with XB/U-cadherin, XBDelta c19, and XBDelta i20 (Fig. 3A) was stained (Fig. 3B). Similarly, the 88-kDa coprecipitating protein was identified as beta -catenin as determined by immunoblotting with beta -catenin antibodies (Fig. 3C). Neither alpha - nor beta -catenin were found in a complex with XBDelta c32 and XBDelta c38 in these Western blots, as expected from their radioimmunoprecipitation profile (Fig. 3A). However, immunodetection of precipitated cadherins with mAb 6D5 showed that all mutants as well as wild-type cadherin were efficiently isolated from cell lysates (Fig. 3D). Thus, detection of alpha - and beta -catenin as XB/U-cadherin coprecipitates did not fail in LXBDelta c32 and LXBDelta c38 lysates because of inefficient immunoisolation of XB/U-cadherin-containing protein complexes with mAb 6D5. In coimmunoprecipitation studies, we did not detect gamma -catenin in a complex with any of the forms of XB/U-cadherin (data not shown).


Fig. 3. Association of XB/U-cadherin and its deletion constructs with alpha - and beta -catenin. Cadherin-transfected L-TK- cells were metabolically labeled with [35S]L-methionine for 16 h. Immune complexes were precipitated with either nonspecific antibodies as controls (lanes a) or with XB/U-cadherin-specific mAb 6D5 (lanes b) and separated on 7.5% polyacrylamide gels. Positions of molecular size standards in thousands are indicated on the left of each gel. A, fluorography of precipitated proteins of transfected L-TK- cells as indicated above each lane. B, immunoprecipitates blotted and probed for alpha -catenin. C, accordingly, beta -catenin was detected in immunoprecipitates. The strong signals at about 45 kDa in B, C, and D represent IgGs and solubilized protein A used for immunoprecipitations, which were detected by secondary antibodies in subsequent immunodetections.
[View Larger Version of this Image (28K GIF file)]

We also analyzed the p120cas-binding properties to full-length and truncated forms of XB/U-cadherin. Interestingly, p120cas was coimmunoprecipitated with wild-type as well as all four deletion mutants of XB/U-cadherin as determined by Western blotting of cadherin immunoprecipitates with antibodies against p120cas (Fig. 4). Although the mAb used reportedly recognizes all four isoforms of p120cas (16), only p120cas 1A and B were found in the complex with XB/U-cadherin.


Fig. 4. Association of XB/U-cadherin and its deletion constructs with p120cas in cadherin-transfected L-TK- cells. Cells were grown to confluency and lysed. Lysates were precipitated with either nonspecific antibodies as controls (lane IgG) or with XB/U-cadherin-specific mAb 6D5 (lanes 6D5) and separated on 7.5% polyacrylamide gels. Immunoprecipitates were blotted and probed for p120cas. p120cas appeared in all samples as a broad band with a molecular weight of 115,000. Lower molecular weight bands that appear in some of the bands were most likely due to protein degradation during the precipitation procedure. Differences of the intensity of bands were not reproducible when compared with several experiments. Positions of molecular size standards in thousands were as indicated.
[View Larger Version of this Image (38K GIF file)]

Effect of Cadherin Truncation on Calcium-dependent Cell Aggregation

The ability of transfected XB/U-cadherin constructs to mediate calcium-dependent cell-cell adhesion was tested using reaggregation assays. Cells were first dissociated by a 5-min trypsin treatment. Reaggregation in the presence of 1 mM Ca2+ resulted in the formation of stable cell-cell contacts within 90 min in L-TK- cells expressing either full-length XB/U-cadherin or mutated XBDelta i20 cDNAs (Fig. 5, A and E). Cell adhesion ability was shown to be calcium-dependent because no cell-cell aggregates were observed in the presence of 1 mM EGTA. An example of this is shown for the XB/U-cadherin-expressing cell line in Fig. 5B. In cells transfected with XBDelta c19, XBDelta c32, or XBDelta c38, or with vector alone, no cell-cell contacts were established; only single cells were observed 90 min after reaggregation was initiated (Fig. 5, C, D, and F, and data not shown).


Fig. 5. Effect of truncated XB/U-cadherin transfection on calciumdependent cell aggregation of L-TK- cells. Transfectant L-TK- cells were dissociated into single cells by treatment with trypsin in the presence of 1 mM calcium chloride and reaggregation in the presence of 1 mM calcium chloride (A, C, D, E, and F) or in the presence of 1 mM EGTA (B) was allowed to occur under slow gyration for 90 min. Cells were fixed and observed for the presence of cell clusters. Representative samples are shown. Transfectants bearing wild-type XB/U-cadherin form aggregates in the presence of Ca2+ (A) but not in the presence of EGTA (B). The three carboxyl-terminal deletion mutants did not mediate calcium-dependent cell adhesion because the respective transfectants did not adhere to each other, as is shown in C for XBDelta c19, in D for XBDelta c32, and in F for XBDelta c38. Conversely, cells transfected with the internal deletion mutant XBDelta i20 were adhesive and formed multicell aggregates in the presence of calcium chloride (E). Bar, 50 µm.
[View Larger Version of this Image (182K GIF file)]

Strikingly, the XB/U-cadherin mutant XBDelta c19 formed complexes with both alpha - and beta -catenin but did not mediate cell-cell adhesion of transfected L-TK- cells. This observation differs from all earlier reports on mutant cadherins in which cadherin-catenin complex formation consistently correlated with cell-cell adhesion.

Surface Localization of XB/U-Cadherin-Catenin Complexes

To further confirm our results on cadherin-catenin complex formation and make sure that complexes were localized to their normal site of function, we tested whether catenins were found associated with the respective XB/U-cadherin forms at plasma membranes. Cell surface molecules were biotinylated and isolated by streptavidin-agarose precipitation. The resulting streptavidin-agarose precipitated proteins and the non-streptavidin-bound cytosolic fraction were separated by SDS-PAGE. Distribution of transfected forms of XB/U-cadherin as well as alpha - and beta -catenins was determined by Western blot analysis using antibodies to catenins or cadherin. Fig. 6A shows the subcellular localization of XB/U-cadherin and its deletion mutants. In all transfected cell lines, cadherin molecules were bound to streptavidin-agarose and were lacking in the soluble supernatant fractions. This provided biochemical evidence that forms of XB/U-cadherin were localized at plasma membranes of transfected cells. alpha - and beta -catenin were detected in plasma membrane-associated fractions of the three cadherin-catenin complex-forming transfectants bearing full-length XB/U-cadherin, XBDelta c19, or XBDelta i20 (Fig. 6B, alpha -catenin; Fig. 6C, beta -catenin). Because catenins do not directly bind to membranes (7), this proved that they were present in surface-associated protein complexes, presumably through interactions with the respective cadherin molecules (refer to Fig. 3). In cell lines that were transfected with vector alone or that expressed the XB/U-cadherin mutants XBDelta c32 or XBDelta c38, alpha - and beta -catenin were detected exclusively in supernatant fractions of the biotinylated cells (Fig. 6, B and C). As expected, catenins remained cytosolic in cells bearing cadherin molecules deficient in cadherin-catenin complex formation. The fact that catenins do not appear in the streptavidin-bound fraction of complex-forming deficient constructs serves as an internal confirmation that the biotinylation was indeed restricted to cell surface molecules.


Fig. 6. Cell surface localization of XB/U-cadherin, its deletion mutants, and bound alpha - and beta -catenin in transfectants. Confluent monolayers of untransfected and transfected L-TK- cells were surface labeled with biotinamidocarproate N-hydroxysuccinimide ester and lysed. 200 µg total protein of each cell line were precipitated with streptavidin-agarose. Non-surface-associated proteins remained in supernatant fractions after streptavidin-agarose incubation, whereas surface-bound proteins were eluted from streptavidin-agarose. Supernatants (lanes SN) and strepavidin-agarose precipitates (lanes SAP) of cell lines, as indicated above each lane, were separated on 7.5% SDS-polyacrylamide gels under reducing conditions and immunoblotted. Positions of molecular size standards in thousands are indicated. A, fractions were probed with XB/U-cadherin antibody 6D5 to show plasma membrane-localized cadherin molecules. B, identical samples were probed with alpha -catenin antibodies to detect surface-associated alpha -catenin. C, all fractions were accordingly analyzed for beta -catenin. Note that due to a higher protein concentration applied per lane, alpha -catenin and beta -catenin can be detected in all L-TK- cell lines analyzed.
[View Larger Version of this Image (55K GIF file)]

Immunofluorescence Analysis of Truncated XB/U-Cadherin Distribution and Detergent Resistance

In agreement with the biochemical data shown in Fig. 6, immunofluorescence staining of nonpermeabilized transfected cells with XB/U-cadherin-specific mAb 6D5 showed that all forms of XB/U-cadherin were localized to the plasma membrane (Fig. 7). The complete XB/U-cadherin as well as XBDelta i20 were predominantly detected at sites of direct cell-cell contact (Fig. 7, A and G). In contrast, XBDelta c19, XBDelta c32, and XBDelta c38 were distributed over the entire cell surface in a punctate pattern (Fig. 7, C, E, and I, respectively). L-TK- cells transfected with vector alone showed no staining with mAb 6D5 (data not shown).


Fig. 7. Immunofluorescent staining of XB/U-cadherin and its deletion constructs in intact and in detergent-extracted transfected L-TK- cells. Cells were grown to confluency on glass coverslips for at least 36 h. For solubilization of membrane proteins, cell layers were incubated with 0.5% Nonidet P-40 for 5 min at 4 °C prior to fixation and staining. Paraformaldehyde-fixed cells were stained with XB/U-cadherin mAb 6D5. Antigens were visualized by incubation with Cy3-conjugated anti-mouse IgG antibodies. L-TK- cells transfected with full-length XB/U-cadherin and its mutated forms stained intact (A, C, E, G, and I) and after detergent extraction (B, D, F, H, and J). A and B, full-length XB/U-cadherin; C and D, XBDelta c19; E and F, XBDelta c32; G and H, XBDelta i20; I and J, XBDelta c38. Note: representative optical sections of each clone are shown by confocal imaging. Bar, 10 µm.
[View Larger Version of this Image (63K GIF file)]

To mediate stable cell-cell adhesion, classical cadherins require linkage to cytoskeletal elements. Because this cytoskeletal stabilization renders cadherin proteins largely resistant to extraction with nonionic detergents (11), transfected L-TK- cells were treated with 0.5% Nonidet P-40 prior to immunostaining with mAb 6D5. A significant amount of transfected XB/U-cadherin (Fig. 7B) as well as the internally deleted mutant XBDelta i20 (Fig. 7H) was resistant to detergent extraction, as illustrated by the pronounced immunofluorescence in regions of cell-cell contact. On the other hand, the three carboxyl-terminal deletion mutants of XB/U-cadherin, XBDelta c19, XBDelta c32, and XBDelta c38, were completely soluble in nonionic detergents. No immunofluorescence signal was obtained when cadherin staining was performed on these cells after Nonidet P-40 extraction (Fig. 7, D, F, and J).


DISCUSSION

Here we report that amphibian XB/U-cadherin associates cytoplasmically with endogenous alpha - and beta -catenin and p120cas when transfected into murine L-TK- fibroblasts. This cadherin-catenin complex induces calcium-dependent cell-cell adhesion, confirming the evolutionary conservation of this adhesion mechanism. The expression of different deletion mutants of XB/U-cadherin shows that p120cas binds upstream of the beta -catenin-binding site. Most interestingly, we observed that XB/U-cadherin detergent insolubility and its ability to mediate cell-cell adhesion requires the 19 most carboxyl-terminal amino acids of XB/U-cadherin, whereas cadherin-catenin complex formation does not. Thus, we provide evidence that two separate domains in the cadherin cytoplasmic tail mediate catenin complex formation and induction of adhesion, respectively.

gamma -Catenin/plakoglobin, instead of beta -catenin, is able to bind to the cytoplasmic tail of E-cadherin (12). Here, XB/U-cadherin predominantly forms complexes with alpha -catenin and beta -catenin, whereas a minor subpopulation of XB/U-cadherin-alpha -, gamma -catenin complexes may exist in our L-TK- transfectants. p120cas coprecipitated with full-length or truncated XB/U-cadherin independently of their function in catenin binding or cell adhesion. This indicates that the p120cas-binding epitope in XB/U-cadherin is located upstream of the 38 carboxyl-terminal amino acids and that the XB/U-cadherin site involved in p120cas binding is not sterically altered by the carboxyl-terminal deletions. Because full-length XB/U-cadherin and the internal deletion mutant XBDelta i20 did not differ from adhesion-deficient mutants XBDelta c19, XBDelta c32, or XBDelta c38 with respect to their gamma -catenin- or p120cas-binding properties, it is not likely that these XB/U-cadherin-binding proteins contribute to the differences in formation and function between XB/U-cadherin-catenin complexes.

The most truncated of our deletion mutants, XBDelta c38, lacks cadherin adhesive function as well as cadherin-catenin complex formation. The interpretation of earlier results from equivalent E-cadherin constructs had been that the catenin-binding domain of E-cadherin reached into the carboxyl-terminal 37 amino acids (9, 19). Our mutants XBDelta c19 and XBDelta c32 both contain the cluster of eight serines but differ in the amino acids following it (Fig. 1A). Because of these mutants, only XBDelta c19 binds catenins, supporting evidence by Stappert and Kemler (22) that amino acids after the serine cluster are necessary for beta -catenin binding. Jou et al. (21) found that these residues were not required for beta -catenin binding. However, this group used the two-hybrid system, which may fail to represent in vivo binding. By attaching the 19 most carboxyl-terminal amino acids to the nonfunctional XBDelta c38, we generated the construct XBDelta i20. Although it lacks a part of the serine cluster as well as the following amino acids, XBDelta i20 does form catenin complexes, suggesting that the 19 most carboxyl-terminal amino acids of XB-cadherin can substitute for the missing sequence. Taken together, our data suggest that the site of beta -catenin interaction is located upstream of the carboxyl-terminal 38 amino acids. Stable beta -catenin binding in vivo, however, requires the cadherin sequences following downstream. These can be substituted by the 19 most carboxyl-terminal amino acids in XBDelta i20 but not by the random sequence in XBDelta c32.

Most strikingly, we learned from our studies that catenin binding itself is not sufficient to render the cadherin-catenin complex adhesive. We could only restore complete cadherin activity by attachment of the 19 most carboxyl-terminal amino acids, which end in seven consecutive acidic residues (XBDelta i20), to the nonfunctional XBDelta c38. The addition of a hydrophobic sequence of equal length (XBDelta c32) neither restored catenin binding nor cell-cell adhesion. Even the addition of the 19 amino acids that normally follow the catenin-binding site (XBDelta c19) were not able to restore complete cadherin activity. This mutant the tail of which contains three acidic residues apart from each other forms cell surface-localized catenin complexes. However, XBDelta c19 fails to mediate cell-cell adhesion. Our data imply that a stretch of acidic amino acids downstream of the catenin-binding site is required to confer adhesive function to the already formed cadherin-catenin complex. Importantly, this shows that the two functions of cadherins, recruitment of cytoplasmic catenins and adhesion, can be separated from each other.

Functional catenin-XB/U-cadherin and -XBDelta i20 complexes cannot be completely solubilized by nonionic detergents, indicating that they are linked to the cytoskeleton (13). Conversely, XBDelta c19 is extracted with mild detergents, probably because its complexes are not stabilized by components of the cytoskeleton.

Complex formation and cytoskeletal linkage seem to depend on the presence of numerous charged amino acids in the catenin-binding domain and in the cadherin tail. Negative charges in the catenin-binding region are provided by posttranslational phosphorylation of multiple serine residues, which has been shown to be essential for catenin binding (22). The binding domain of plakoglobin, a beta -catenin homologue, in the desmosomal cadherin desmoglein bears an accumulation of negatively charged amino acids as well (29, 30). More recently, a beta -catenin-binding site has been identified in the amino terminus of the transcription factor LEF-1. This domain also consists of many negatively charged amino acids (31, 32). beta -Catenin has been shown to bind to the product of the tumor suppressor gene apc in vivo (33-36). APC bears multiple consensus sequences for beta -catenin interaction, which lack any similarity with the cadherin cytoplasmic tail and are devoid of negatively charged residues (35). alpha -Catenin also interacts with the APC-beta -catenin complex, presumably in a manner similar to how it binds to the beta -catenin-cadherin complex. However, APC-beta -catenin complexes are not induced to interact with the cytoskeleton when bound to alpha -catenin. Thus, a protein complex including beta - and alpha -catenin does not, by default, associate with cytoskeletal elements. Given that alpha -beta -catenin complexes serve functions in vivo as soluble complexes in the cytoplasm as well as membrane- and microfilament-associated, cytoskeletal binding of catenins must be specifically regulated. Our results suggest that this regulation is performed by cadherin cytoplasmic sequences distinct from the beta -catenin-binding site.


FOOTNOTES

*   This work was supported by Deutsche Forschungsgemeinschaft grants to D. W.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Present address: Margaret M. Dyson Vision Research Institute, LC305, Cornell University Medical College, 1300 York Ave., New York, NY 10021.
§   To whom correspondence should be addressed: Department of Biochemistry, University of Ulm, Albert Einstein Allee 11, D-89081 Ulm, Germany. Tel.: 49(0)731-5023283; Fax: 49(0)731-5023277; E-mail: Doris.Wedlich{at}medizin.uni-ulm.de.
1   The abbreviation used is: mAb, monoclonal antibody.

ACKNOWLEDGEMENTS

The technical assistance of Ulrike Unsöld is greatly appreciated. We are grateful to Drs. Peter Hausen and Rolf Kemler for the donation of antibodies. We also thank Dr. Geri Gurland for critical reading of the manuscript.


REFERENCES

  1. Kühl, M., and Wedlich, D. (1996) Dev. Dyn. 207, 121-134 [CrossRef][Medline] [Order article via Infotrieve]
  2. Müller, A., Kühl, M., Finnemann, S., Schneider, S., van der Poel, S., Hausen, P., and Wedlich, D. (1994) Mech. Dev. 47, 213-223 [Medline] [Order article via Infotrieve]
  3. Kühl, M., Finnemann, S., Binder, O., and Wedlich, D. (1996) Mech. Dev. 54, 71-82 [CrossRef][Medline] [Order article via Infotrieve]
  4. Dufour, S., Saint-Jeannet, J.-P., Broders, F., Wedlich, D., and Thiery, J. P. (1994) J. Cell Biol. 127, 521-535 [Abstract]
  5. Redies, C., and Müller, A. (1994) Cell Adhesion Commun. 2, 511-520 [Medline] [Order article via Infotrieve]
  6. Tsukita, S., Tsukita, S., Nagafuchi, A., and Yonemura, S. (1992) Curr. Opin. Cell. Biol. 4, 834-839 [Medline] [Order article via Infotrieve]
  7. Kemler, R. (1993) Trends Genet. 9, 317-321 [CrossRef][Medline] [Order article via Infotrieve]
  8. Takeichi, M. (1995) Curr. Opin. Cell Biol. 7, 619-627 [CrossRef][Medline] [Order article via Infotrieve]
  9. Ozawa, M., Baribault, H., and Kemler, R. (1989) EMBO J. 8, 1711-1717 [Abstract]
  10. Ozawa, M., and Kemler, R. (1992) J. Cell Biol. 116, 989-996 [Abstract]
  11. Aberle, H., Butz, S., Stappert, J., Weissig, H., Kemler, R., and Hoschuetzky, H. (1994) J. Cell Sci. 107, 3655-3663 [Abstract/Free Full Text]
  12. Hinck, L., Näthke, I. S., Papkoff, J., and Nelson, W. J. (1994) J. Cell Biol. 125, 1327-1340 [Abstract]
  13. Nagafuchi, A., Ishihara, S., and Tsukita, S. (1994) J. Cell Biol. 127, 235-245 [Abstract]
  14. Aberle, H., Schwartz, H., Hoschuetzky, H., and Kemler, R. (1996) J. Biol. Chem. 271, 1520-1526 [Abstract/Free Full Text]
  15. Knudsen, K. A., Soler, A. P., Johnson, K. R., and Wheelock, M. J. (1995) J. Cell Biol. 130, 67-77 [Abstract]
  16. Reynolds, A. B., Daniel, J., McCrea, P., Wheelock, M. J., Wu, J., and Zhang, Z. (1994) Mol. Cell. Biol. 14, 8333-8342 [Abstract]
  17. Daniel, J. M., and Reynolds, A. B. (1995) Mol. Cell. Biol. 15, 4819-4824 [Abstract]
  18. Shibamoto, S., Hayakawa, M., Takeuchi, K., Hori, T., Miyazawa, K., Kitamura, N., Johnson, K., Wheelock, M. J., Matsuyoshi, N., Takeichi, M., and Ito, F. (1995) J. Cell Biol. 128, 949-957 [Abstract]
  19. Nagafuchi, A., and Takeichi, M. (1989) Cell Regul. 1, 37-44 [Medline] [Order article via Infotrieve]
  20. Ozawa, M., Ringwald, M., and Kemler, R. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 4246-4250 [Abstract]
  21. Jou, T.-S., Stewart, D. B., Stappert, J., Nelson, W. J., and Marrs, J. A. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5067-5071 [Abstract]
  22. Stappert, J., and Kemler, R. (1994) Cell Adhesion Commun. 2, 319-327 [Medline] [Order article via Infotrieve]
  23. Finnemann, S., Kühl, M., Otto, G., and Wedlich, D. (1995) Mol. Cell. Biol. 15, 5082-5091 [Abstract]
  24. Angres, B., Müller, A. H., and Hausen, P. (1991) Development (Camb.) 111, 829-844 [Abstract]
  25. Herrenknecht, K., Ozawa, M., Eckerskorn, C., Lottspeich, F., Lenter, M., and Kemler, R. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 9156-9160 [Abstract]
  26. Butz, S., Stappert, J., Weissig, H., and Kemler, R. (1992) Science 257, 1142-1143 [Medline] [Order article via Infotrieve]
  27. Takeichi, M. (1977) J. Cell Biol. 75, 464-474 [Abstract]
  28. Kowalczyk, A. P., Palka, H. L., Luu, H. H., Nilles, L. A., Anderson, J. E., Wheelock, M. J., and Green, K. J. (1994) J. Biol. Chem. 269, 31214-31223 [Abstract/Free Full Text]
  29. Mathur, M., Goodwin, L., and Cowin, P. (1994) J. Biol. Chem. 269, 14075-14080 [Abstract/Free Full Text]
  30. Troyanovski, S. M., Troyanovski, R. B., Eshkind, L. G., Krutovskikh, V. A, Leube, R. E., and Franke, W. (1994) J. Cell Biol. 127, 151-160 [Abstract]
  31. Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. (1996) Nature 382, 638-642 [CrossRef][Medline] [Order article via Infotrieve]
  32. Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destree, O., and Clevers, H. (1996) Cell 86, 391-399 [Medline] [Order article via Infotrieve]
  33. Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S., Masiarz, F., Munemitsu, S., and Polakis, P. (1993) Science 262, 1731-1734 [Medline] [Order article via Infotrieve]
  34. Su, L. K., Vogelstein, B., and Kinzler, K. W. (1993) Science 262, 1734-1737 [Medline] [Order article via Infotrieve]
  35. Hülsken, J., Birchmeier, W., and Behrens, J. (1994) J. Cell Biol. 127, 2061-2069 [Abstract]
  36. Polakis, P. (1995) Curr. Opin. Genet. Dev. 5, 66-71 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.